65 related articles for article (PubMed ID: 18645048)
1. Inappropriate left ventricular mass in patients with primary aldosteronism.
Muiesan ML; Salvetti M; Paini A; Agabiti-Rosei C; Monteduro C; Galbassini G; Belotti E; Aggiusti C; Rizzoni D; Castellano M; Agabiti-Rosei E
Hypertension; 2008 Sep; 52(3):529-34. PubMed ID: 18645048
[TBL] [Abstract][Full Text] [Related]
2. Subclinical Primary Aldosteronism and Cardiovascular Health: A Population-Based Cohort Study.
Hundemer GL; Agharazii M; Madore F; Vaidya A; Brown JM; Leung AA; Kline GA; Larose E; Piché ME; Crean AM; Shaw JLV; Ramsay T; Hametner B; Wassertheurer S; Sood MM; Hiremath S; Ruzicka M; Goupil R
Circulation; 2024 Jan; 149(2):124-134. PubMed ID: 38031887
[TBL] [Abstract][Full Text] [Related]
3. Gender Differences in Cardiac Organ Damage in Arterial Hypertension: Assessing the Role of Drug Nonadherence.
Aune A; Ohldieck A; Halvorsen LV; Brobak KM; Olsen E; Rognstad S; Larstorp ACK; Søraas CL; Rossebø AB; Rösner A; Grytaas MA; Gerdts E
High Blood Press Cardiovasc Prev; 2024 Mar; 31(2):157-166. PubMed ID: 38530572
[TBL] [Abstract][Full Text] [Related]
4. Impact of a family history of hypertension and physical activity on left ventricular mass.
Callaghan KN; Hosick PA; Brian MS; Matthews EL
J Sports Med Phys Fitness; 2023 Aug; 63(8):949-956. PubMed ID: 37158799
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis.
Monticone S; D'Ascenzo F; Moretti C; Williams TA; Veglio F; Gaita F; Mulatero P
Lancet Diabetes Endocrinol; 2018 Jan; 6(1):41-50. PubMed ID: 29129575
[TBL] [Abstract][Full Text] [Related]
6. The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study.
Brown JM; Siddiqui M; Calhoun DA; Carey RM; Hopkins PN; Williams GH; Vaidya A
Ann Intern Med; 2020 Jul; 173(1):10-20. PubMed ID: 32449886
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of primary aldosteronism and association with cardiovascular complications in patients with resistant and refractory hypertension.
Parasiliti-Caprino M; Lopez C; Prencipe N; Lucatello B; Settanni F; Giraudo G; Rossato D; Mengozzi G; Ghigo E; Benso A; Maccario M
J Hypertens; 2020 Sep; 38(9):1841-1848. PubMed ID: 32384388
[TBL] [Abstract][Full Text] [Related]
8. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Funder JW; Carey RM; Mantero F; Murad MH; Reincke M; Shibata H; Stowasser M; Young WF
J Clin Endocrinol Metab; 2016 May; 101(5):1889-916. PubMed ID: 26934393
[TBL] [Abstract][Full Text] [Related]
9. Risk of dementia in primary aldosteronism compared with essential hypertension: a nationwide cohort study.
Hong N; Kim KJ; Yu MH; Jeong SH; Lee S; Lim JS; Rhee Y
Alzheimers Res Ther; 2023 Aug; 15(1):136. PubMed ID: 37568223
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular and metabolic characters of
Chang YY; Lee BC; Chen ZW; Tsai CH; Chang CC; Liao CW; Pan CT; Peng KY; Chou CH; Lu CC; Wu VC; Hung CS; Lin YH;
Front Endocrinol (Lausanne); 2023; 14():1061704. PubMed ID: 36950676
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and clinical characteristics of primary aldosteronism in a tertiary-care center in Korea.
Yoon M; Hong N; Ha J; Lee CJ; Ku CR; Rhee Y; Park S
Hypertens Res; 2022 Sep; 45(9):1418-1429. PubMed ID: 35681044
[TBL] [Abstract][Full Text] [Related]
12. Strain Imaging for the Early Detection of Cardiac Remodeling and Dysfunction in Primary Aldosteronism.
Chen Y; Xu T; Xu J; Zhu L; Wang D; Li Y; Wang J
Diagnostics (Basel); 2022 Feb; 12(2):. PubMed ID: 35204632
[TBL] [Abstract][Full Text] [Related]
13. Cerebro-Cardiovascular Risk, Target Organ Damage, and Treatment Outcomes in Primary Aldosteronism.
Lin X; Ullah MHE; Wu X; Xu F; Shan SK; Lei LM; Yuan LQ; Liu J
Front Cardiovasc Med; 2021; 8():798364. PubMed ID: 35187110
[TBL] [Abstract][Full Text] [Related]
14. CMR-Verified Myocardial Fibrosis Is Associated With Subclinical Diastolic Dysfunction in Primary Aldosteronism Patients.
Zhou F; Wu T; Wang W; Cheng W; Wan S; Tian H; Chen T; Sun J; Ren Y
Front Endocrinol (Lausanne); 2021; 12():672557. PubMed ID: 34054733
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic and Non-Hemodynamic Components of Cardiac Remodeling in Primary Aldosteronism.
Pan CT; Wu XM; Tsai CH; Chang YY; Chen ZW; Chang CC; Lee BC; Liao CW; Chen YL; Lin LC; Chang YR; Hung CS; Lin YH
Front Endocrinol (Lausanne); 2021; 12():646097. PubMed ID: 33953695
[TBL] [Abstract][Full Text] [Related]
16. Minor Change of Plasma Renin Activity during the Saline Infusion Test Provide an Auxiliary Diagnostic Value for Primary Aldosteronism.
Adilijiang M; Luo Q; Wang M; Zhang D; Yao X; Wang G; Zhou K; Li N
Int J Endocrinol; 2021; 2021():5757305. PubMed ID: 33679972
[TBL] [Abstract][Full Text] [Related]
17. Diurnal blood pressure pattern and cardiac damage in hypertensive patients with primary aldosteronism.
Wu Q; Hong M; Xu J; Tang X; Zhu L; Gao P; Wang J
Endocrine; 2021 Jun; 72(3):835-843. PubMed ID: 33474712
[TBL] [Abstract][Full Text] [Related]
18. Associations Between Metabolic Profiles and Target-Organ Damage in Chinese Individuals With Primary Aldosteronism.
Zhang SL; Gao JW; Guo Y; Feng QL; Tang JY; Yan L; Wang JF; Cheng H; Liu PM
Front Endocrinol (Lausanne); 2020; 11():547356. PubMed ID: 33101195
[No Abstract] [Full Text] [Related]
19. Left ventricular remodeling and dysfunction in primary aldosteronism.
Tsai CH; Pan CT; Chang YY; Chen ZW; Wu VC; Hung CS; Lin YH
J Hum Hypertens; 2021 Feb; 35(2):131-147. PubMed ID: 33067554
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
